For 10 winters, 608 children five years old or younger who were hospitalized with respiratory syncytial virus (RSV) infection were prospectively studied to evaluate the relation between their immune status and the severity of their infection. Forty-seven had been immunocompromised by chemotherapy, steroid therapy, or a primary immunodeficiency disorder. Among the immunocompromised children, those receiving chemotherapy for cancer and those with immunodeficiency disease had more severe RSV disease, with pneumonia occurring at all ages, and a higher mortality rate. Children receiving long-term steroid therapy did not appear to have more severe clinical manifestations than normal children. Viral shedding, however, was significantly greater and more prolonged in the children receiving steroid therapy, and particularly in those receiving chemotherapy or with an immunodeficiency disease. Giant-cell pneumonia was documented in one child with leukemia. Over half the immunocompromised children acquired the RSV infection nosocomially. These findings indicate that children receiving chemotherapy for cancer and those with immunodeficiency disease are at risk for complicated or fatal infections from RSV and should be considered for antiviral and other therapies as they become available. Efforts should also be made to protect compromised children if hospitalization cannot be avoided.
This article has been cited by other articles:
Frey, S., Krempl, C. D., Schmitt-Graff, A., Ehl, S.
(2008). Role of T Cells in Virus Control and Disease after Infection with Pneumonia Virus of Mice. J. Virol.
82: 11619-11627
[Abstract][Full Text]
Miyairi, I., DeVincenzo, J. P.
(2008). Human Genetic Factors and Respiratory Syncytial Virus Disease Severity. Clin. Microbiol. Rev.
21: 686-703
[Abstract][Full Text]
Yanney, M, Vyas, H
(2008). The treatment of bronchiolitis. Arch. Dis. Child.
93: 793-798
[Abstract][Full Text]
El Saleeby, C. M., Somes, G. W., DeVincenzo, J. P., Gaur, A. H.
(2008). Risk Factors for Severe Respiratory Syncytial Virus Disease in Children With Cancer: The Importance of Lymphopenia and Young Age. Pediatrics
121: 235-243
[Abstract][Full Text]
Vallbracht, S., Jessen, B., Mrusek, S., Enders, A., Collins, P. L., Ehl, S., Krempl, C. D.
(2007). Influence of a Single Viral Epitope on T Cell Response and Disease After Infection of Mice with Respiratory Syncytial Virus. J. Immunol.
179: 8264-8273
[Abstract][Full Text]
Heidema, J., Lukens, M. V., van Maren, W. W. C., van Dijk, M. E. A., Otten, H. G., van Vught, A. J., van der Werff, D. B. M., van Gestel, S. J. P., Semple, M. G., Smyth, R. L., Kimpen, J. L. L., van Bleek, G. M.
(2007). CD8+ T Cell Responses in Bronchoalveolar Lavage Fluid and Peripheral Blood Mononuclear Cells of Infants with Severe Primary Respiratory Syncytial Virus Infections. J. Immunol.
179: 8410-8417
[Abstract][Full Text]
Harris, J.-A. S., Huskins, W. C., Langley, J. M., Siegel, J. D., for the Pediatric Special Interest Group of the So,
(2007). Health Care Epidemiology Perspective on the October 2006 Recommendations of the Subcommittee on Diagnosis and Management of Bronchiolitis. Pediatrics
120: 890-892
[Full Text]
Liu, B., Kimura, Y.
(2007). Local immune response to respiratory syncytial virus infection is diminished in senescence-accelerated mice. J. Gen. Virol.
88: 2552-2558
[Abstract][Full Text]
Howidi, M., Rajah, J., Abushrar, Z., Parsons, H.
(2007). The Severity of Respiratory Syncytial Virus Bronchiolitis in Young Infants in the United Arab Emirates. J Trop Pediatr
53: 22-26
[Abstract][Full Text]
Sasai, M., Shingai, M., Funami, K., Yoneyama, M., Fujita, T., Matsumoto, M., Seya, T.
(2006). NAK-Associated Protein 1 Participates in Both the TLR3 and the Cytoplasmic Pathways in Type I IFN Induction. J. Immunol.
177: 8676-8683
[Abstract][Full Text]
Stensballe, L. G., Kristensen, K., Simoes, E. A.F., Jensen, H., Nielsen, J., Benn, C. S., Aaby, P., for the Danish RSV Data Network,
(2006). Atopic Disposition, Wheezing, and Subsequent Respiratory Syncytial Virus Hospitalization in Danish Children Younger Than 18 Months: A Nested Case-Control Study. Pediatrics
118: e1360-e1368
[Abstract][Full Text]
Subcommittee on Diagnosis and Management of Bronch,
(2006). Diagnosis and Management of Bronchiolitis. Pediatrics
118: 1774-1793
[Abstract][Full Text]
Meiring, H. D., Soethout, E. C., Poelen, M. C. M., Mooibroek, D., Hoogerbrugge, R., Timmermans, H., Boog, C. J., Heck, A. J. R., de Jong, A. P. J. M., van Els, C. A. C. M.
(2006). Stable Isotope Tagging of Epitopes: A Highly Selective Strategy For The Identification Of Major Histocompatibility Complex Class I-Associated Peptides Induced Upon Viral Infection. Mol. Cell. Proteomics
5: 902-913
[Abstract][Full Text]
Falsey, A. R., Formica, M. A., Hennessey, P. A., Criddle, M. M., Sullender, W. M., Walsh, E. E.
(2006). Detection of Respiratory Syncytial Virus in Adults with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med.
173: 639-643
[Abstract][Full Text]
Choudhuri, J. A., Ogden, L. G., Ruttenber, A. J., Thomas, D. S.K., Todd, J. K., Simoes, E. A.F.
(2006). Effect of Altitude on Hospitalizations for Respiratory Syncytial Virus Infection. Pediatrics
117: 349-356
[Abstract][Full Text]
de Graaff, P. M. A., de Jong, E. C., van Capel, T. M., van Dijk, M. E. A., Roholl, P. J. M., Boes, J., Luytjes, W., Kimpen, J. L. L., van Bleek, G. M.
(2005). Respiratory Syncytial Virus Infection of Monocyte-Derived Dendritic Cells Decreases Their Capacity to Activate CD4 T Cells. J. Immunol.
175: 5904-5911
[Abstract][Full Text]
Leidy, N. K., Margolis, M. K., Marcin, J. P., Flynn, J. A., Frankel, L. R., Johnson, S., Langkamp, D., Simoes, E. A. F.
(2005). The Impact of Severe Respiratory Syncytial Virus on the Child, Caregiver, and Family During Hospitalization and Recovery. Pediatrics
115: 1536-1546
[Abstract][Full Text]
Zhao, X., Sullender, W. M.
(2005). In Vivo Selection of Respiratory Syncytial Viruses Resistant to Palivizumab. J. Virol.
79: 3962-3968
[Abstract][Full Text]
Heidema, J., de Bree, G. J., de Graaff, P. M. A., van Maren, W. W. C., Hoogerhout, P., Out, T. A., Kimpen, J. L. L., van Bleek, G. M.
(2004). Human CD8+ T cell responses against five newly identified respiratory syncytial virus-derived epitopes. J. Gen. Virol.
85: 2365-2374
[Abstract][Full Text]
Singleton, R., Etchart, N., Hou, S., Hyland, L.
(2003). Inability To Evoke a Long-Lasting Protective Immune Response to Respiratory Syncytial Virus Infection in Mice Correlates with Ineffective Nasal Antibody Responses. J. Virol.
77: 11303-11311
[Abstract][Full Text]
van Elden, L. J. R., van Loon, A. M., van der Beek, A., Hendriksen, K. A. W., Hoepelman, A. I. M., van Kraaij, M. G. J., Schipper, P., Nijhuis, M.
(2003). Applicability of a Real-Time Quantitative PCR Assay for Diagnosis of Respiratory Syncytial Virus Infection in Immunocompromised Adults. J. Clin. Microbiol.
41: 4378-4381
[Abstract][Full Text]
Johnson, T. R., Parker, R. A., Johnson, J. E., Graham, B. S.
(2003). IL-13 Is Sufficient for Respiratory Syncytial Virus G Glycoprotein-Induced Eosinophilia After Respiratory Syncytial Virus Challenge. J. Immunol.
170: 2037-2045
[Abstract][Full Text]
van Bleek, G. M., Poelen, M. C., van der Most, R., Brugghe, H. F., Timmermans, H. A. M., Boog, C. J., Hoogerhout, P., Otten, H. G., van Els, C. A. C. M.
(2002). Identification of Immunodominant Epitopes Derived from the Respiratory Syncytial Virus Fusion Protein That Are Recognized by Human CD4 T Cells. J. Virol.
77: 980-988
[Abstract][Full Text]
Viuff, B., Tjornehoj, K., Larsen, L. E., Rontved, C. M., Uttenthal, A., Ronsholt, L., Alexandersen, S.
(2002). Replication and Clearance of Respiratory Syncytial Virus: Apoptosis Is an Important Pathway of Virus Clearance after Experimental Infection with Bovine Respiratory Syncytial Virus. Am. J. Pathol.
161: 2195-2207
[Abstract][Full Text]
Kamal-Bahl, S., Doshi, J., Campbell, J.
(2002). Economic Analyses of Respiratory Syncytial Virus Immunoprophylaxis in High-Risk Infants: A Systematic Review. Arch Pediatr Adolesc Med
156: 1034-1041
[Abstract][Full Text]
Bockova, J., O'Brien, K. L., Oski, J., Croll, J., Reid, R., Weatherholtz, R. C., Santosham, M., Karron, R. A.
(2002). Respiratory Syncytial Virus Infection in Navajo and White Mountain Apache Children. Pediatrics
110: e20-20
[Abstract][Full Text]
Haynes, L. M., Tonkin, J., Anderson, L. J., Tripp, R. A.
(2002). Neutralizing Anti-F Glycoprotein and Anti-Substance P Antibody Treatment Effectively Reduces Infection and Inflammation Associated with Respiratory Syncytial Virus Infection. J. Virol.
76: 6873-6881
[Abstract][Full Text]
Jones, L. P., Zheng, H.-Q., Karron, R. A., Peret, T. C. T., Tsou, C., Anderson, L. J.
(2002). Multiplex Assay for Detection of Strain-Specific Antibodies against the Two Variable Regions of the G Protein of Respiratory Syncytial Virus. CVI
9: 633-638
[Abstract][Full Text]
Kahn, J. S., Roberts, A., Weibel, C., Buonocore, L., Rose, J. K.
(2001). Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge. J. Virol.
75: 11079-11087
[Abstract][Full Text]
Carlsen, K-;H., Sterk, P.J.
(2001). Infection: friend or foe to the development of asthma?. Eur Respir J
18: 744-747
[Full Text]
Meissner, H. C.
(2001). Uncertainty in the Management of Viral Lower Respiratory Tract Disease. Pediatrics
108: 1000-1003
[Full Text]
Hall, C. B.
(2001). Respiratory Syncytial Virus and Parainfluenza Virus. NEJM
344: 1917-1928
[Full Text]
Goulder, P. J. R., Lechner, F., Klenerman, P., McIntosh, K., Walker, B. D.
(2000). Characterization of a Novel Respiratory Syncytial Virus-Specific Human Cytotoxic T-Lymphocyte Epitope. J. Virol.
74: 7694-7697
[Abstract][Full Text]
Falsey, A. R., Walsh, E. E.
(2000). Respiratory Syncytial Virus Infection in Adults. Clin. Microbiol. Rev.
13: 371-384
[Abstract][Full Text]
Plotnicky-Gilquin, H., Robert, A., Chevalet, L., Haeuw, J.-F., Beck, A., Bonnefoy, J.-Y., Brandt, C., Siegrist, C.-A., Nguyen, T. N., Power, U. F.
(2000). CD4+ T-Cell-Mediated Antiviral Protection of the Upper Respiratory Tract in BALB/c Mice following Parenteral Immunization with a Recombinant Respiratory Syncytial Virus G Protein Fragment. J. Virol.
74: 3455-3463
[Abstract][Full Text]
GUERGUERIAN, A.-M., GAUTHIER, M., LEBEL, M. H., FARRELL, C. A., LACROIX, J.
(1999). Ribavirin in Ventilated Respiratory Syncytial Virus Bronchiolitis . A Randomized, Placebo-controlled Trial. Am. J. Respir. Crit. Care Med.
160: 829-834
[Abstract][Full Text]
Domachowske, J. B., Rosenberg, H. F.
(1999). Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment. Clin. Microbiol. Rev.
12: 298-309
[Abstract][Full Text]
Whitehead, S. S., Bukreyev, A., Teng, M. N., Firestone, C.-Y., St. Claire, M., Elkins, W. R., Collins, P. L., Murphy, B. R.
(1999). Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees. J. Virol.
73: 3438-3442
[Abstract][Full Text]
MOLER, F. W., OHMIT, S. E.
(1999). Severity Of Illness Models For Respiratory Syncytial Virus-Associated Hospitalization. Am. J. Respir. Crit. Care Med.
159: 1234-1240
[Abstract][Full Text]
Committee on Infectious Diseases and Committee on,
(1998). Prevention of Respiratory Syncytial Virus Infections: Indications for the Use of Palivizumab and Update on the Use of RSV-IGIV. Pediatrics
102: 1211-1216
[Abstract][Full Text]
Rodriguez, W. J., Gruber, W. C., Groothuis, J. R., Simoes, E. A. F., Rosas, A. J., Lepow, M., , A. K., Hemming, V., the RSV-IGIV Study Group,
(1997). Respiratory Syncytial Virus Immune Globulin Treatment of RSV Lower Respiratory Tract Infection in Previously Healthy Children. Pediatrics
100: 937-942
[Abstract][Full Text]
Brandenburg, A. H, Jeannet, P.-Y., Steensel-Moll, H. A v, Ott, A., Rothbarth, P. H, Wunderli, W., Suter, S., Neijens, H. J, Osterhaus, A. D M E, Siegrist, C.-A.
(1997). Local variability in respiratory syncytial virus disease severity. Arch. Dis. Child.
77: 410-414
[Abstract][Full Text]
ROMN, M., CALHOUN, W. J., HINTON, K. L., AVENDAO, L. F., SIMON, V., ESCOBAR, A. M., GAGGERO, A., DAZ, P. V.
(1997). Respiratory Syncytial Virus Infection in Infants Is Associated with Predominant Th-2-like Response. Am. J. Respir. Crit. Care Med.
156: 190-195
[Abstract][Full Text]
Committee on Infectious Diseases, , Committee on Fetus and Newborn,
(1997). Respiratory Syncytial Virus Immune Globulin Intravenous: Indications for Use. Pediatrics
99: 645-650
[Abstract][Full Text]
Law, B. J., Wang, E. E. L., MacDonald, N., McDonald, J., Dobson, S., Boucher, F., Langley, J., Robinson, J., Mitchell, I., Stephens, D.
(1997). Does Ribavirin Impact on the Hospital Course of Children With Respiratory Syncytial Virus (RSV) Infection? An Analysis Using the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) RSV Database. Pediatrics
99: e7-e7
[Abstract][Full Text]
Rodriguez, W. J., Gruber, W. C., Welliver, R. C., Groothuis, J. R., Simoes, E. A. F., Meissner, H. C., Hemming, V. G., Hall, C. B., Lepow, M. L., Rosas, A. J., Robertsen, C., Kramer, A. A.
(1997). Respiratory Syncytial Virus (RSV) Immune Globulin Intravenous Therapy for RSV Lower Respiratory Tract Infection in Infants and Young Children at High Risk for Severe RSV Infections. Pediatrics
99: 454-461
[Abstract][Full Text]
Fisher, R. G., Gruber, W. C., Edwards, K. M., Reed, G. W., Tollefson, S. J., Thompson, J. M., Wright, P. F.
(1997). Twenty Years of Outpatient Respiratory Syncytial Virus Infection: A Framework for Vaccine Efficacy Trials. Pediatrics
99: e7-e7
[Abstract][Full Text]
Schneider, S., Borzy, M. S.
(1996). Fatal Respiratory Syncytial Virus Pneumonia as the Presenting Feature of Severe Combined Immunodeficiency Disease. CLIN PEDIATR
35: 147-149
Isaacs, D.
(1995). Bronchiolitis. BMJ
310: 4-5
[Full Text]
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., Tristram, D. A., Siber, G. R., Prince, G. A., Van Raden, M., Hemming, V. G., The Respiratory Syncytial Virus Immune Globulin St,
(1993). Prophylactic Administration of Respiratory Syncytial Virus Immune Globulin to High-Risk Infants and Young Children. NEJM
329: 1524-1530
[Abstract][Full Text]
La Via, W. V., Grant, S. W., Stutman, H. R., Marks, M. I.
(1993). Clinical Profile of Pediatric Patients Hospitalized With Respiratory Syncytial Virus Infection. CLIN PEDIATR
32: 450-454
[Abstract]
